Drug Profile
Calpeptin
Latest Information Update: 12 Jan 1996
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Research Corporation Technologies
- Class Anti-ischaemics
- Mechanism of Action Calpain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis
Most Recent Events
- 10 Jan 1996 New profile
- 10 Jan 1996 Discontinued-Preclinical for Coronary artery restenosis in USA (Unknown route)